Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment

Sofie Hallager^*, Steen Ladelund, Nina Weis

^*Corresponding author for this work

1 Citation (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{260d98b806de48a2ad14c3c7e94175e6,

title = "Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment",

author = "Sofie Hallager and Steen Ladelund and Nina Weis",

year = "2017",

month = aug,

doi = "10.1016/j.jhep.2017.02.035",

language = "English",

volume = "67",

pages = "427--428",

journal = "Journal of Hepatology, Supplement",

issn = "0169-5185",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Methodological considerations when calculating person-time at risk for patients with chronic hepatitis C undergoing antiviral treatment

AU - Hallager, Sofie

AU - Ladelund, Steen

AU - Weis, Nina

PY - 2017/8

Y1 - 2017/8

U2 - 10.1016/j.jhep.2017.02.035

DO - 10.1016/j.jhep.2017.02.035

M3 - Comment/debate

C2 - 28435039

AN - SCOPUS:85019074905

SN - 0169-5185

VL - 67

SP - 427

EP - 428

JO - Journal of Hepatology, Supplement

JF - Journal of Hepatology, Supplement

IS - 2

ER -